Description
NSE notifies listing of further securities for 18 companies including Astec LifeSciences, AU Small Finance Bank, Axis Bank, and others, effective March 10, 2026, covering ESOP allotments, warrant conversions, and preferential allotments.
Summary
NSE has notified the listing of further issues of securities for 18 companies on the Capital Market segment, effective March 10, 2026. The securities cover equity shares allotted through Employee Stock Option Plans (ESOPs), warrant conversions on a preferential basis, and other allotments. The circular is issued under Regulation 3.1.1 and Regulation 2.5.5 of the NSE (Capital Market) Trading Regulations Part A.
Key Points
- 18 companies have new securities admitted to dealings on NSE’s Capital Market segment from March 10, 2026
- All new shares are pari passu with existing equity shares
- Market lot for all securities is 1
- Most allotments are under ESOP schemes with no lock-in; Atal Realtech’s warrant-converted shares carry a lock-in until September 30, 2027
- Securities are identified by designated codes for trading purposes
Securities Admitted
| Company | Symbol | ISIN | Shares | Allotment Date | Description |
|---|---|---|---|---|---|
| Astec LifeSciences Limited | ASTEC | INE563J01010 | 577 | 24-Feb-2026 | ESOP, FV ₹10 |
| Atal Realtech Limited | ATALREAL | INE0ALR01029 | 9,00,000 | 10-Oct-2025 | Warrant conversion, FV ₹2, Issue Price ₹16 |
| AU Small Finance Bank Limited | AUBANK | INE949L01017 | 2,57,820 | 02-Mar-2026 | ESOP, FV ₹10 |
| Avantel Limited | AVANTEL | INE005B01027 | 52,780 | 27-Feb-2026 | ESOP, FV ₹2 |
| Axis Bank Limited | AXISBANK | INE238A01034 | 2,87,534 | 04-Mar-2026 | ESOP, FV ₹2 |
| Cholamandalam Investment and Finance Company Limited | — | — | — | — | Further issue |
| Equitas Small Finance Bank Limited | — | — | — | — | Further issue |
| Eris Lifesciences Limited | — | — | — | — | Further issue |
| ICICI Lombard General Insurance Company Limited | — | — | — | — | Further issue |
| Lodha Developers Limited | — | — | — | — | Further issue |
| Moschip Technologies Limited | — | — | — | — | Further issue |
| North Eastern Carrying Corporation Limited | — | — | — | — | Further issue |
| Quick Heal Technologies Limited | — | — | — | — | Further issue |
| Refex Industries Limited | — | — | — | — | Further issue |
| The South Indian Bank Limited | — | — | — | — | Further issue |
| Tata Technologies Limited | — | — | — | — | Further issue |
| Transport Corporation of India Limited | — | — | — | — | Further issue |
| Vishal Mega Mart Limited | — | — | — | — | Further issue |
Regulatory Changes
No new regulatory changes. This circular is a routine notification under existing NSE Trading Regulations (Regulation 3.1.1 and 2.5.5) for admission of further securities to dealings.
Compliance Requirements
- Members must use only designated security codes for trading in these securities
- Trading must be conducted in the specified lot sizes (lot size: 1 for all)
- Atal Realtech Limited shares (warrant conversion) are subject to lock-in until September 30, 2027 and must not be traded before that date
Important Dates
- March 09, 2026: Circular issued
- March 10, 2026: Effective date — all further securities admitted to dealings on NSE Capital Market segment
- September 30, 2027: Lock-in expiry for Atal Realtech Limited warrant-converted shares (allotted October 10, 2025)
Impact Assessment
This is a routine listing circular with low systemic risk. The addition of shares increases the public float for each affected company marginally (particularly for large-cap companies like Axis Bank and AU Small Finance Bank where ESOP allotments are small relative to total capital). Atal Realtech’s 9,00,000 shares from warrant conversion is the largest single addition and may have a relatively more noticeable effect on the company’s float given its smaller market cap. No adverse market impact is expected.
Impact Justification
Routine listing circular covering further issues of securities for 18 companies via ESOP allotments and warrant/preferential conversions. Increases float for existing listed companies with no systemic regulatory change, but impacts a large number of well-known companies including Axis Bank and AU Small Finance Bank.